BIOME Oléoactif® is an exclusive active ingredient that regulates skin microbiota and reinforces skin barrier function, thanks to a unique composition of innovative active molecules.This fermentation-derived active is produced by a wild extremophile microorganism from DEINOVE’s collection and extracted by Hallstar France’s patented oleo-eco-extraction process.This new ingredient will be officially launched in April 2020.DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics, announces the upcoming official commercial launch (in April 2020) of the first cosmetic active ingredient resulting from its collaboration1with Hallstar France, BIOME Oléoactif®.BIOME Oléoactif® is the first oil-based active ingredient obtained by extracting rare branched fatty acids from a wild extremophile microorganism into a blend of jojoba liquid wax and oat oil. It contains unique and original fatty acids – specific to bacteria, totally absent from the vegetal world – supplemented by polar lipids, known for their moisturizing properties and recognized as being an effective active principle vehicle.BIOME Oléoactif® is a postbiotic extract with a prebiotic effect: it both balances the skin microbiota and maintains the integrity of the epidermal barrier. Besides its moisturizing, restructuring, soothing and emollient properties, BIOME Oléoactif® can be combined with all types of ingredients to create a holistic system that promotes healthy, youthful, beautiful skin.As the heaviest and most extensive organ of the human body (about 2 sq.m. and 4-10 kg), the skin naturally maintains its own “micro-ecosystem”, which is constantly evolving throughout life. The micro-organisms present on and in the skin, collectively called cutaneous microbiota, play a real protective role: anti-inflammatory, anti-infectious, antioxidant and repairing. It is considered an integral part of skin barrier that, combined with innate immunity, is essential for maintaining the skin health. An imbalance in the microbiota – which may be caused by such factors as diet, hormonal imbalance, lifestyle – can then lead to several skin disorders, such as dandruff, acne, psoriasis, or atopic dermatitis.“BIOME Oléoactif® is produced from a rare extremophile bacterium, collected in a hot spring, that DEINOVE has managed to cultivate, and whose potential is enhanced through the original extraction technique developed by Oléos (a French company that become part of Hallstar Beauty in 2016). With this active ingredient, we are positioning ourselves as a key player delivering innovation in skin microbiome products, increasingly popular in the cosmetics industry. Most of DEINOVE strains are naturally present in the human microbiota, thus offering opportunities for the development of pro- and postbiotics ingredients. 2020 promises to be a prolific year for our cosmetics developments”, says Coralie MARTIN, Marketing Manager of DEINOVE.“BIOME Oléoactif® is our first product leveraging the microscopic world. It provides innovative compounds, which are not found in the rest of the natural world, including the plant world. This is an exciting area, that we are glad to enter”,adds Anne ROSSIGNOL-CASTERA, Hallstar’s General and Scientific Manager for Active Naturals.ABOUT HALLSTARHallstar is a leading global provider of specialty chemistry solutions. The company takes a collaborative approach to every engagement, delivering technical support, chemistry expertise and industry knowledge. Hallstar’s Active Naturals line of products, developed exclusively in France, are next-generation natural, 100% eco-designed cosmetic ingredients, based on its patented oleo-eco-extraction technology. These products rely on the synergy between the properties of vegetable oils together with the bio-molecules naturally present in plants, flowers, fruits and minerals.https://www.hallstarbeauty.com/ABOUT DEINOVEDEINOVE is a French biotechnology company, a leader in disruptive innovation, which aims to help meet the challenges of antibiotic resistance and the transition to a sustainable production model for the cosmetics and nutrition industries.DEINOVE has developed a unique and comprehensive expertise in the field of rare bacteria that it can decipher, culture, and optimize to disclose unsuspected possibilities and induce them to produce biobased molecules with activities of interest on an industrial scale. To do so, DEINOVE has been building and documenting since its creation an unparalleled biodiversity bank that it exploits thanks to a unique technological platform in Europe.DEINOVE is organized around two areas of expertise:ANTIBIOTICS, New-generation anti-infective drugs: A first antibiotic candidate, DNV3837, is now in Phase II. The Company is also pursuing the systematic exploration of biodiversity to supply its portfolio with new leads, drawing notably on partnerships with bioMérieux and Naicons (AGIR program supported by Bpifrance).BIOACTIVES, Active ingredients of natural origin with cosmetics as the first market: DEINOVE is already marketing a first cosmetic active ingredient, a second in partnership with Greentech and plans to launch new assets in 2020. Several other cosmetic actives are in development, including with Hallstar and Dow. It also runs a program in animal nutrition with Groupe Avril.Within the Euromedecine science park located in Montpellier, DEINOVE employs 60 employees, mainly researchers, engineers, and technicians, and has filed more than 350 patent applications internationally. The Company has been listed on EURONEXT GROWTH® since April 2010.CONTACTS Investors Coralie Martin Communication, Marketing and Investor Relations Ph.: +33 (0)6 46 62 47 50 coralie.martin@deinove.com Media ALIZE RP Caroline Carmagnol Ph.: +33 (0)6 64 18 99 59 deinove@alizerp.com 1 Cf. Press release dated 30 January 2018 Attachment200318-DEINOVE_PR_launch-cosmetic-active_Hallstar_final
Before you continue, please confirm the following:
Professional advisers only
I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.
Important Notice for Investors:
The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.
No Investment Advice:
The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.
High Risks:
Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.
Sole Responsibility:
The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.
No Guarantees:
Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.
Regional Restrictions:
The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.
Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.